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The HIV-1 envelope (Env) spike contains limited epi-
topes for broadly neutralizing antibodies (bNAbs);
thus, most neutralizing antibodies are strain specific.
The 8ANC195 epitope, defined by crystal and elec-
tron microscopy (EM) structures of bNAb 8ANC195
complexed with monomeric gp120 and trimeric
Env, respectively, spans the gp120 and gp41 Env
subunits. To investigate 8ANC195’s gp41 epitope at
higher resolution, we solved a 3.58 A˚ crystal structure
of 8ANC195 complexed with fully glycosylated Env
trimer, revealing 8ANC195 insertion into a glycan
shield gap to contact gp120 and gp41 glycans and
protein residues. To determine whether 8ANC195
recognizes the CD4-bound open Env conformation
that leads to co-receptor binding and fusion, one of
several known conformations of virion-associated
Env, we solved EM structures of an Env/CD4/CD4-
induced antibody/8ANC195 complex. 8ANC195
binding partially closed the CD4-bound trimer, con-
firming structural plasticity of Env by revealing a
previously unseen conformation. 8ANC195’s ability
to bind different Env conformations suggests advan-
tages for potential therapeutic applications.INTRODUCTION
The envelope (Env) spike of HIV-1, a trimer of gp120-gp41 heter-
odimers, is the only target of neutralizing antibodies (Abs) and
therefore the focus of vaccine design efforts. The discovery of
highly potent broadly neutralizing antibodies (bNAbs) isolated
froma subset of HIV-1-infected donors has brought new impetus
to the idea of delivering bNAbs passively to protect against or
treat HIV-1 infection. bNAbs have been shown to prevent and
treat infection in mouse and macaque models (reviewed in
West et al., 2014) and exhibited efficacy against HIV-1 in a hu-
man clinical trial (Caskey et al., 2015). Defining the epitopes
and neutralization mechanisms of anti-HIV-1 bNAbs provides
critical information for selecting combinations of bNAbs for
passive delivery efforts and for design of immunogens to elicit
similar Abs in a vaccine and can illuminate the complex process
of viral entry.CUntil recently, the HIV-1 Env spikewas considered to have four
defined bNAb epitopes: three on the gp120 subunit (the V1V2-
glycan epitope at the apex of the Env trimer, the V3-loop region
centered on the Asn332gp120 oligomannose patch, and the bind-
ing site for the host receptor CD4) and the fourth involving the
gp41 membrane-proximal external region (MPER) (reviewed in
West et al., 2014). Within the last year, three Abs were discov-
ered to target distinct regions of the gp120-gp41 interface.
Two of the subunit-spanning bNAbs, PGT151 and 35O22, are
trimer specific and do not bind to gp120 monomers (Blattner
et al., 2014; Huang et al., 2014). The gp120-gp41-spanning
bNAb 8ANC195 binds both to gp120 monomers and gp140 tri-
mers (Scharf et al., 2014; Scheid et al., 2011).
8ANC195 was originally isolated in a screen that identified
many CD4-binding site (CD4bs) Abs, but its epitope did not
map as a conventional CD4bs bNAb (Scheid et al., 2011).
We used computational analyses of neutralization data to
predict that intact potential N-linked glycosylation sites at posi-
tions 234gp120 and 276gp120 are essential for the activity of
8ANC195, suggesting that the epitope was near, but not within,
the CD4bs on gp120 (West et al., 2013). A 3.0 A˚ resolution crystal
structure of 8ANC195 Fab and CD4 domains 1 and 2 (sCD4)
bound to a gp120 core revealed extensive contacts with
N-linked glycans attached to Asn234gp120 and Asn276gp120
and defined a site of Env vulnerability involving glycans and the
gp120 inner domain that is not targeted by other bNAbs (Scharf
et al., 2014). Finally, negative-stain single-particle electron mi-
croscopy (EM) reconstruction of a native-like soluble Env trimer
(BG505 SOSIP.664, hereafter referred to as BG505 SOSIP
[Sanders et al., 2013]) complexed with three 8ANC195 Fabs
confirmed the binding site on gp120 and further suggested
that 8ANC195 spanned the gp120-gp41 subunit interface to
contact gp120 with its heavy chain (HC) and gp41 with its light
chain (LC) (Scharf et al., 2014). These structural studies sug-
gested that 8ANC195 did not inhibit HIV-1 infection by blocking
the CD4bs on gp120 (indeed, the crystal structure demonstrated
simultaneous binding of sCD4 and 8ANC195 Fab) but, rather,
that recognition of both Env subunits by 8ANC195 could
facilitate neutralization by preventing conformational changes
required for gp41-mediated fusion of the host cell and viral
membranes.
However, the precise nature of the 8ANC195 epitope on gp41
could not be elucidated due to the low resolution of the
8ANC195-BG505 SOSIP EM structure; nor was it known
whether 8ANC195would block or accommodate conformational
changes in Env trimers upon CD4 binding. To address theseell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc. 1379
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Figure 1. Overview of 8ANC195G52K5-BG505
SOSIP Structure
8ANC195G52K5 Fabs are dark pink (HC) and light
pink (LC), gp120 subunits are different shades of
light gray, and gp41 subunits are different shades
of dark gray. N-linked glycans at the Fab-trimer
interface are yellow.
(A) 8ANC195G52K5-Env structure seen from the top
in space-filling (left) and ribbon diagram (right)
representations.
(B) 8ANC195G52K5-Env structure seen from the side
in space-filling (left) and ribbon diagram (right)
representations.
(C) Conformations of HIV-1 Env trimers shown
schematically (adapted from figures in Liu et al.,
2008) as seen from above (top) and the side
(bottom) (CD4-binding site, yellow; remainder of
gp120, light gray; gp41, dark gray; membrane,
blue-gray). The closed structure was observed for
unliganded virion-bound trimers (Liu et al., 2008)
and structures involving liganded BG505 SOSIP
trimers (Julien et al., 2013a; Lyumkis et al., 2013;
Pancera et al., 2014). The partially open structure
was observed for virion-bound trimers associated
with b12 or A12 (Liu et al., 2008). Open structures
were observed for trimers associated with CD4 or
the Fab from the CD4-induced Ab 17b (Merk and
Subramaniam, 2013).
See also Figure S1 and Table S1.questions, we solved a crystal structure of an 8ANC195-BG505
SOSIP complex to define the 8ANC195 epitope at the gp120-
gp41 interface at atomic resolution, allowing structural compar-
ison of a subunit-spanning bNAb bound to a gp120 monomer
and to a gp140 Env trimer. Furthermore, we used binding studies
to show that 8ANC195 can recognize CD4-bound Env trimers;
thus, the conformational changes induced by CD4 binding do
not preclude 8ANC195 recognition of the gp120-gp41 interface.
To visualize the conformational state of Env trimer bound to
both CD4 and 8ANC195, we used three-dimensional (3D) EM
reconstruction to demonstrate that 8ANC195 binding prevents
the full opening of Env trimer that is associated with the con-
formational change induced by CD4 to allow subsequent co-
receptor binding and fusion of host and viral membranes.
These studies provide structural and biochemical evidence of
a bNAb recognizing both the closed and open conformational
states of HIV-1 Env and suggest that the ability to accommodate1380 Cell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc.conformational change on its target anti-
gen benefits an anti-HIV-1 bNAb.
RESULTS
Characterization of Complete
8ANC195 Epitope in the Context of
HIV-1 Env Trimer
To elucidate the complete 8ANC195
epitope on Env trimer at atomic resolution,
we solved a 3.58 A˚ resolution crystal
structure of a more potent 8ANC195
variant, g52HCk5LC (Scharf et al., 2014)(hereafter referred to as 8ANC195G52K5), complexed with
BG505 SOSIP (Figure 1 and Table S1). Trimers were expressed
in kifunensine-treated HEK cells to yield protein containing
Man8-9GlcNAc2 high-mannose N-glycans (Elbein et al., 1990)
at all potential N-linked glycosylation sites (pseudoviruses
containing only high-mannose glycans or mixtures of high-
mannose and complex glycans were neutralized equivalently
by 8ANC195G52K5; Table S3). Crystallization trials were conduct-
ed with complexes of BG505 SOSIP, sCD4, and 8ANC195G52K5
Fab produced by first purifying BG505 SOSIP complexed with
sCD4 by size exclusion chromatography (SEC) (Figures S1A
and S1B), adding 8ANC195G52K5 Fab, and then repeating the
SEC to purify the ternary complex (Figure S1C). Although the
crystallization drops contained all three proteins, resulting crys-
tals did not include sCD4 (Figure S1D), and electron density
maps showed density only for one BG505 SOSIP and three
8ANC195G52K5 Fabs per asymmetric unit. When we docked
three copies of sCD4 in the appropriate location on BG505
SOSIP by aligning the gp120-sCD4 portion of the 8ANC195-
gp120-sCD4 complex structure (PDB: 4P9H) with gp120 in the
trimer portion of 8ANC195G52K5-BG505 SOSIP structure and
refined their all-atom occupancies, the occupancies of sCD4
atoms refined toward zero, confirming the absence of sub-stoi-
chiometric amounts of sCD4 in the crystals.
The 8ANC195G52K5-BG505 SOSIP structure revealed the
variable heavy (VH), variable light (VL), and constant heavy and
light (CH1 and CL) domains of three Fabs bound at the gp120-
gp41 interface of an Env trimer (Figures 1A and 1B). The trimer
is in the closed, prefusion state, similar to the conformation of
BG505 SOSIP in previous crystal and EM structures (Julien
et al., 2013a; Do Kwon et al., 2015; Lyumkis et al., 2013; Pancera
et al., 2014) and as revealed for bNAb-bound BG505 SOSIP by
hydrogen-deuterium exchange (Guttman et al., 2015), rather
than the open conformation observed in EM structures of both
virion-associated and soluble Env trimers, including sCD4 or
the CD4-induced Ab 17b (Harris et al., 2011; Liu et al., 2008;
Sanders et al., 2013; Tran et al., 2012) (Figure 1C). Since no
Abs were bound to the apex of the trimer in our crystals, by
contrast with previous crystal structures of BG505 SOSIP bound
to PGT122 (Julien et al., 2013a) or PGT122 and 35O22 (Pancera
et al., 2014), the V1/V2 loops of the trimer in the 8ANC195G52K5-
BG505 SOSIP structure are less ordered (Figure S1E). However,
well-resolved regions of the trimer showed no major structural
rearrangements compared with a previous structure of similar
resolution (PDB: 4TVP) (Figure S1E). Trimers for previous crystal
structures contained only high-mannose N-linked glycans that
were treatedwith EndoH to truncate accessibleN-linked glycans
to a single N-acetyl glucosamine (NAG) (Julien et al., 2013a; Do
Kwon et al., 2015; Pancera et al., 2014), whereas our trimer
structure includes all potential N-linked glycans in an untrun-
cated form. Nevertheless, we observed nomajor conformational
changes compared with previous structures, with the exception
of some disordering of the trimer apex, likely due to the lack of
stabilization by crystal contacts or Fab binding to this region.
The placement of the 8ANC195G52K5 VH domain relative to the
gp120 subunit of gp140 was relatively close to that observed in
the 8ANC195-gp120-sCD4 complex structure (Ca rmsd of 2.1 A˚;
all VH residues), with closest agreement at the 8ANC195G52K5-
gp120 interface (Figure S2A). The interactions with gp120 are
reproduced in the context of the trimer, including contacts with
protein residues in the gp120 inner domain andwithN-linked gly-
cans at Asn234gp120 and Asn276gp120 (Figures 2A, 2B, and 3 and
Table S2). The Asn276gp120 glycan, normally complex type in
native HIV-1 Envs (Binley et al., 2010; Go et al., 2011), is high
mannose in the crystallized Env trimer. This gp120 glycan forms
an interface with framework region residues in VH domain
strands A and B and the N-terminal portion of CDRH1 using
only the core pentasaccharide common to both high-mannose
and complex-typeN-glycans (Scharf et al., 2014), which we sug-
gested is an adaptation to recognize both complex-type and
high-mannose glycans at a particular N-linked glycosylation
site on Env (Mouquet et al., 2012; Scharf et al., 2014). The overall
conformation of VH is conserved (Ca rmsd of 0.67 A˚ after aligning
all VH residues). However, there are rearrangements in the resi-
dues of the third complementarity determining region of theCHC (CDRH3) to accommodate and interact with gp41 (Figures
2B, 3, S2C, and S2D). Furthermore, VL is shifted slightly from
the position observed in the 8ANC195-gp120-sCD4 structure,
also to accommodate and interact with gp41 (Figures 2B, 3,
S2C, and S2D). Compared with the low-resolution EM recon-
struction (Scharf et al., 2014), the 8ANC195G52K5-BG505 SOSIP
crystal structure shows a closer interaction of the Fab and trimer,
confirming the Fab placement observed in the complex structure
with gp120 (Figure S2E).
As described previously, 8ANC195 contacts a large epitope
on gp120 alone (3,750 A˚2 of total buried surface area in gp120-
8ANC195-sCD4 structure [Scharf et al., 2014]). The interface
on gp120 is 3,835 A˚2 in the context of the trimer (Figures 2A
and 2B and Table S2), and contacts with gp41 make the
8ANC195G52K5 epitope more extensive, adding 1,810 A˚
2 total
buried surface area between gp41 and the Fab (485 A˚2 between
gp41 and HC; 1,325 A˚2 between gp41 and LC). 771 A˚2 of this
interface is between the LC and the Asn637gp41 glycan, which
is ordered to the branching mannose (MAN) residue in the core
pentasaccharide (NAG-NAG-MAN) (Figures 2C and 3). The first
CDR of the LC, CDRL1, stabilizes CDRH3 and interacts with res-
idues near the kink in a9gp41 (nomenclature for gp41 secondary
structures as in Pancera et al., 2014) and residues 613gp41–
615gp41 in a loop N terminal to a8gp41 that is positioned under-
neath the kink in a9gp41 at Asn637gp41 (Figures 2C and 3). This
interaction rationalizes our previous observation that a germline
(gl) reversion that altered two residues and removed one from
CDRL1 (T30SLC, G30aDLC, N31SLC) drastically decreased the
potency of 8ANC195 (Scharf et al., 2014), possibly because
Gly30aLC introduces a kink in CDRL1 that allows the mature
Ab to engage and accommodate this region of gp41. The second
LC CDR, CDRL2, mainly accommodates the Asn637gp41 glycan
(Figure 2C). A conservative two-residue gl reversion in this loop
(G51ALC, A52SLC) caused a large decrease in neutralization po-
tency (Scharf et al., 2014), likely because the loop in the mature
Ab containing Gly51LC-Ala52LC is more compact and flexible,
allowing the LC to avoid clashes with the Asn637gp41 glycan.
Thr30LC is within hydrogen-bonding distance of Glu634gp41
and Ser615gp41 side chains and the backbone carbonyl oxygen
of Tyr638LC. Other LC residues in CDRL1 and CDRL2 in the
vicinity of gp41 could participate in water-mediated H bonds
(Asn31LC, Trp32LC, Arg50LC, Gly51LC, and Leu54LC), but we
cannot place water molecules at the current resolution.
To determine the functional importance of gp41 contacts by
8ANC195, we assessed the effects of alanine mutants of
8ANC195 HC and LC residues located in the vicinity of gp41 in
the 8ANC195G52K5-BG505 SOSIP structure (Table S3 and Fig-
ure 3). 8ANC195 IgG mutants W32ALC, Y49ALC, and Y91ALC
showed decreased neutralization potencies against HIV-1
strains YU2 and BG505, and W100aAHC showed slightly
decreased potency against YU2 (Table S3). These results are
rationalized by the complex structure (Figure 3): Trp100aHC,
conserved in all 8ANC195-related HCs (Scharf et al., 2014),
inserts its side chain into a hydrophobic pocket at the gp120-
gp41 interface, suggesting that the loss of this interaction
reduces the binding energy. The W32ALC mutation resulted in
a complete loss of neutralization potency against YU2 and
BG505. Trp32LC makes no direct contacts with gp41 but couldell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc. 1381
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Figure 2. Interfaces in 8ANC195G52K5-BG505 SOSIP Structure
(A) 8ANC195G52K5 epitope. BG505 SOSIP is shown in space-filling representation with the gp120 and gp41 portions of one protomer in white and medium gray,
respectively (other two protomers are light gray). Glycan and protein portions of the 8ANC195G52K5 epitope are highlighted in the indicated colors on one
protomer.
(B) Close-up of contact areas. Relevant portions of 8ANC195G52K5 are shown in wire representation with atoms within buried surface areas on BG505 SOSIP
shown as colored surfaces.
(C) Details of interactions with glycans on gp120 and gp41. Buried surface areas on 8ANC195G52K5 are shown as colored surfaces.
See also Figure S2 and Table S2.engage in water-mediated H bonds with Glu634gp41. In addition,
it makes stacking interactions with His100fHC side chain, likely
stabilizing the complicated CDRH3 conformation involved in
gp120 interactions (Scharf et al., 2014). The hydroxyl group of
Tyr49LC is within hydrogen-bonding distance of the branching
mannose of the Asn637gp41 glycan, potentially allowing the Ab
to accommodate this conserved glycan, and the ring portion of
the side chain makes hydrophobic interactions with Leu100dHC,
potentially stabilizing the CDRH3 conformation. The hydroxyl
group of Tyr91LC forms H bonds with Gly100cHC and Lys50LC,
again stabilizing the CDRH3 conformation.
Effects of N-Linked Glycans Attached to gp41
on Neutralization by 8ANC195
To further explore the roles of N-linked glycans within the
8ANC195 epitope on gp41, we evaluated the effects of1382 Cell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc.removing glycans attached to Asn611gp41, Asn625gp41, and
Asn637gp41 (by one, two, or three Asn-Gln mutations) on YU2
pseudovirus neutralization by WT 8ANC195 and partially gl-re-
verted chimeric Abs.
Neutralization by 8ANC195 did not depend strongly upon the
presence of glycans attached to Asn611gp41, Asn625gp41, or
Asn637gp41 (Table S4). However, glycan recognition may play a
more prominent role during maturation of 8ANC195 from its gl
progenitor, as evidenced by neutralization behaviors of partial
gl chimeric LCs. 8ANC195 containing a gl reversion that altered
two residues and removed one from CRDL1 (T30SLC, G30aDLC,
N31SLC) (8ANC195 glCDRL1) exhibited >130-fold reduced
neutralization potency against YU2 compared to the fully mature
Ab, but its neutralization capacity was completely ablated if the
Env target lacked glycosylation at Asn611gp41 or Asn625gp41.
These glycans may have partially stabilized Ab binding in
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Figure 3. Contacts between 8ANC195G52K5 Fab and BG505 SOSIP Protein Residues and Glycans
Proteins are shown as Ca traces with interface residues as sticks (oxygen, red; nitrogen, blue). CDRs and framework regions (FWRs) of 8ANC195G52K5 at the
interface are highlighted and labeled. Putative H bonds are shown as yellow dots. Env glycans at the interface are yellow (Asn234gp120), orange (Asn276gp120), and
tan (Asn637gp41) and are enclosed in electron density from a 2Fo-Fc simulated annealing omit map contoured at 1.0 s (gray mesh) in the lower structure panels.
Schematic structures of the ordered portions of these N-linked glycans are shown at the bottom.
See also Tables S3 and S4.progenitors of the mature 8ANC195, which would have had
shortened CDRL1 loops in addition to two amino acid substitu-
tions. Conversely, glycosylation at Asn637gp41 may destabilizeCbinding of progenitor Abs since neutralization potency of
8ANC195 glCDRL1 against YU2 was partially restored (16-fold)
when the Asn637gp41 site was knocked out. The destabilizingell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc. 1383
AB
Figure 4. Effects of Env Trimer Conforma-
tional State on Binding Affinity of 8ANC195
(A) Schematic representation of coupled surfaces
and injectedanalytes.A control IgG (mG053), an IgG
recognizing closed trimers (PGT121 or PGT145),
CD4-Fc (recognizing open trimers), and a CD4-
induced Ab (17b or 21c) recognizing open CD4-
bound trimers were immobilized on separate flow
cells of abiosensorchip.BG505SOSIP trimerswere
injected, resulting in binding to surfaces except for
the control flow cell. 8ANC195, 8ANC195G52K5, or a
G52HC/8ANC195LC chimera Fab was then injected
over the IgG-BG505 SOSIP complex.
(B) Summary of affinities (KD values; reported as
mean ± SD for three independent experiments) for
combinations of capture proteins and analytes.
Since PGT145 indirectly inhibited binding of
8ANC195 to BG505 SOSIP trimers and PGT121
enhanced 8ANC195 binding (Derking et al., 2015),
our affinity measurements likely underestimated
(PGT145-captured trimers) or overestimated
(PGT121-captured trimers) the affinity of 8ANC195
for closed trimer. N.D., not determined.
See also Figure S3.influence of Asn637gp41 glycosylation had a greater effect than
stabilizing influences of Asn611gp41 and Asn625gp41 glycans,
as the net effect in double or triple knockouts involving
Asn637gp41 was only partial restoration of neutralizing activity.
In the case of a target with an Asn611gp41/Asn637gp41 double
knockout, neutralization by 8ANC195 glCDRL1 was improved
by >30-fold and was brought to within the same order of magni-
tude as mature 8ANC195.
8ANC195 containing a conservative two-residue gl reversion
in CDRL2 (G51ALC, A52SLC) (8ANC195 glCDRL2) was 16-fold
reduced in neutralization potency compared to the mature Ab;
its remaining potency was further diminished by 8.6-fold if the
YU2 Env lacked glycosylation at Asn625gp41 but was partially
restored (1.8-fold) if it lacked glycosylation at Asn637gp41. The
restorative effect of the knockout of Asn637gp41-linked glyco-
sylation was again dominant over effects of also removing
Asn625gp41-linked glycan in a double knockout. The knockout
of Asn611gp41-linked glycosylation had only a minor effect
on neutralization by 8ANC195 glCDRL2 but amplified the restor-
ative effect of the Asn637gp41 knockout from 1.8-fold to >8-fold
in the double and triple knockouts. The CDRL2 loop lies in
apposition to the glycan attached to Asn637gp41 in the
8ANC195G52K5-BG505 SOSIP crystal structure and 15 A˚ from
the Asn611gp41 glycosylation site (Figure 3). Given the closer
proximity of CDRL2 to the Asn637gp41 glycan, interactions be-
tween the two might be influenced synergistically by a loss of
glycosylation at Asn611gp41. In the case of a chimeric Ab con-
taining the mature 8ANC195 HC and a gl LC (8ANC195 mHC/
glLC), which had a 19-fold reduced neutralization potency
against YU2, a stabilizing effect of Asn611gp41 glycosylation
and destabilizing effect of Asn637gp41 glycosylation were evident
in several of the pairings.
These results are consistent with Asn637gp41 glycosyla-
tion interfering with neutralization of a partially immature
8ANC195, Asn625gp41 glycosylation enhancing neutralization,1384 Cell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc.and Asn611gp41 glycosylation having positive or detrimental
effects depending on complex factors. Mature 8ANC195 may
have evolved promiscuity toward recognition of viruses contain-
ing or lacking glycans at these positions. Such viruses may be
present in a viral swarm containing many mutated viruses. The
evolution of promiscuous recognition may have arisen through
layers of redundancy in stabilizing interactions that are only re-
vealed on partial reversion to the gl form. Thus, we speculate
that mature 8ANC195 accommodates, rather than productively
interacts with, at least some of the gp41 glycans.
8ANC195 Binds CD4-Bound Env Trimers
We previously showed that 8ANC195 and sCD4 can bind simul-
taneously to monomeric gp120 and that addition of sCD4 did not
detectably alter the in vitro neutralization potency of 8ANC195
(Scharf et al., 2014). sCD4 binding has little to no effect on the
structures of monomeric gp120 cores (Kwon et al., 2012) but re-
sults in rotation of gp120 protomers to create an open structure
in virion-bound Env trimers and SOSIP gp140s, including BG505
SOSIP (Harris et al., 2011; Liu et al., 2008; Sanders et al., 2013;
Tran et al., 2012) (Figure 1C). Although sCD4 does not preclude
binding of 8ANC195 to gp120, changes between the closed and
open states of trimeric Env at the gp120-gp41 interface could
disrupt the 8ANC195 epitope on open Env trimers.
To determine whether 8ANC195 can bind sCD4-bound open
Env trimers, we used SPR to evaluate binding to different trimer
conformational states. For these experiments, we immobilized
IgGs on a biosensor chip that captured BG505 SOSIP trimers
with different bNAbs: PGT145 and PGT121, which bind to closed
Env (Julien et al., 2013a; Pancera et al., 2014; Pugach et al.,
2015); CD4-Fc (Capon et al., 1989), which should capture open
trimers; and CD4-induced Abs 17b and 21c (Sullivan et al.,
1998; Xiang et al., 2002), which should capture sCD4-bound
open trimers (Figures 4A and S3). 17b Fab induces opening of
some Env trimers in the absence of CD4 binding (Tran et al.,
Top view Side view Bottom view
8ANC195G52K5 17b sCD4 gp120
90º
90º 90º
90º 90º
90º
A
B
C
Figure 5. EM Reconstructions of BG505
SOSIP-sCD4-17b-8ANC195G52K5 Complex
The X-ray structures of a gp120-scD4-17b com-
plex (PDB: 1RZK) and 8ANC195 Fab (PDB: 4P9M)
were fit to EM densities and are shown from the
top, side, and bottom.
(A) 23 A˚ resolution EM density derived from cryo-
ET and sub-tomogram averaging.
(B) 17 A˚ resolution EM density derived from
negative-stain single-particle reconstruction.
(C) Superposition of densities from cryo-ET/sub-
tomogram averaging (cyan) and negative-stain
single-particle (light gray) reconstructions.
See also Figures S4 and S5.2012), but 17b does not bind to BG505 SOSIP unless sCD4 is
present (Sanders et al., 2013), and the 21c epitope includes por-
tions of CD4 as well as gp120 (Diskin et al., 2010). Thus, both
CD4-induced Abs will only bind to sCD4-BG505 SOSIP
complexes.
8ANC195 and 8ANC195G52K5 Fabs were injected over the
trimer-bound surface to determine their affinities for BG505
SOSIP in its closed and open states. 8ANC195, 8ANC195G52K5,
and a chimeric Fab differing from 8ANC195 only in the K100RHC
mutation (8ANC195G52K5 HC/8ANC195 LC) bound to closed
trimer with slightly higher affinities than to CD4-Fc-bound open
trimer (Figures 4B and S3). No decrease in affinity was observed
for 8ANC195G52K5 binding to CD4-bound BG505 SOSIP
captured by 17b or 21c, perhaps reflecting stabilization of
the 8ANC195G52K5-sCD4-BG505 SOSIP complex by the CD4-
induced Abs.
We also attempted to determine a binding affinity for the
interaction between 8ANC195 IgG-bound BG505 SOSIP
trimers and sCD4. In reciprocal experiments to those described
above, sCD4was injected over 8ANC195-captured trimers. Only
weak binding that could not be fit to a binding model was
observed (Figure S3). Since sCD4 binds to unliganded BG505
SOSIP (Julien et al., 2013b) (Figures S1A and S1B), this result
suggests that pre-binding of 8ANC195 to Env diminishes its
ability to interact with CD4.Cell 162, 1379–1390, Se8ANC195 Recognizes a Partially
Open Env Trimer in the Presence
of sCD4 and 17b
Having shown that it is possible for
8ANC195/8ANC195G52K5 to recognize
CD4-bound BG505 SOSIP trimers, we
sought to determine how this class of Ab
accommodates conformational changes
involved in transitioning from the
closed to open trimeric state (Figure 1C).
We prepared complexes of BG505
SOSIP trimers, sCD4, 17b Fab, and
8ANC195G52K5 Fab for EM structure de-
terminations (Figures 5, 6, S4, and S5),
reasoning that binding of 17b Fab to a
CD4-bound open trimer would prevent a
potential full reversion to a closed trimeric
conformation since it is not possible toaccommodate three 17b Fabs at the apex of a closed gp140
trimer (Figure 6A). To ensure that the trimers were in an open
conformationwhen given the opportunity to bind 8ANC195G52K5,
we first purified BG505 SOSIP-sCD4-17b complexes by SEC,
added 8ANC195G52K5 Fab, and then subjected the four-compo-
nent mixture to SEC again, obtaining stable quaternary com-
plexes, as confirmed by SDS-PAGE (Figure S4A).
In order to obtain a reference-free reconstruction of the BG505
SOSIP-sCD4-17b-8ANC195G52K5 complex that included no
assumptions about trimer conformation or how many ligands
were bound, we initially determined a 23 A˚ structure by sub-
tomogram averaging of cryoelectron tomography (cryo-ET)
data obtained from 3D reconstruction of a tilt series of two-
dimensional (2D) projection images (Figures 5A and S4). With
no model or symmetry imposed, the sub-tomogram-averaged
structure showed a 3-fold symmetric particle with densities for
three 17b Fabs at the apex, three sCD4 molecules around the
middle, and three 8ANC195G52K5 Fabs at the bottom. Since a
co-crystal structure of gp120-sCD4-17b can be fit as a unit
into EM structures of open CD4-bound Env trimers (Harris
et al., 2011; Liu et al., 2008; Sanders et al., 2013), we first fit
the density with gp120-sCD4-17b coordinates (PDB: 1RZK), re-
sulting in a 3-fold symmetric distribution of gp120, sCD4, and
17b.We next fit 8ANC195 Fab (PDB: 4P9M) into three protruding
densities at the predicted gp120-gp41-spanning epitope.ptember 10, 2015 ª2015 Elsevier Inc. 1385
AC
B Figure 6. Comparison of Different Conforma-
tions of Env Trimers in BG505 SOSIP-sCD4-
17b-8ANC195G52K5 and Other Env Trimer
Complexes Illustrated by 17b and gp120
Positions
(A) Overlay of 17b Fabs from BG505 SOSIP-sCD4-
17b-8ANC195G52K5 complex (gray space-filling
representations) with 17b Fabs complexed with Env
trimers in different conformational states (thick Ca
traces in shades of blue). 17b Fabs shown after su-
perimposition of gp120s from trimers (trimers and
other ligands not shown). (Left) 17b modeled onto
3DNN coordinates of a closed trimer. (Middle) 17b
modeled onto 3DNL coordinates of a partly open
trimer. (Right) 17b taken from 3DNO structure of a
CD4- and 17b-bound open trimer. Note that three
17b Fabs cannot be accommodated without clashes
when modeled onto the gp120s of closed and partly
open trimer structures.
(B) Ca trace of the three 17b Fabs from the BG505
SOSIP-sCD4-17b-8ANC195G52K5 complex.
(C) Positions of gp120s (gray space-filling repre-
sentation with locations of CD4-binding site in yel-
low, V3 loop in green, and base of V1V2 domain in
red) in Env trimers adopting the indicated confor-
mations. The locations of Asp368gp120 are shown as
a black dot for each trimer conformation, with the
distance between the Ca of this residue in adjacent
protomers indicated. Distances are presented as the
mean and SD for the analogous distance in repre-
sentative structures in each conformation.
See also Figure S6 and Table S5.To verify and extend the structural details, we next determined
a negative-stain single-particle reconstruction of the BG505
SOSIP-sCD4-17b-8ANC195G52K5 complex at 17 A˚ resolution
(Figures 5B and S5). Potentially due to conditions during staining
or drying of the grid or the low-sample concentrations necessary
to obtain grids containing an optimal distribution of particles, not
all complexes contained stoichiometric numbers of ligands.
Therefore, we included a 3D classification procedure after
reference-free 2D classification to sort particles containing the
stoichiometric complex from sub-stoichiometric complexes,
resulting in selection of approximately half of the initially selected
particles from good 2D classes. The resulting reconstruction
showed density for three copies each of 8ANC195G52K5, 17b,
and sCD4 bound to BG505 SOSIP, and we again fit the density
using coordinates for gp120-sCD4-17b and 8ANC195 Fab
structures (Figure 5B). The two reconstructions showed similar
placements of three gp120s, three sCD4s, and six Fabs (Figures
5C).We used the higher-resolution single-particle reconstruction
for subsequent analyses.
From comparisons with other Fab- and Fab-sCD4-Env struc-
tures, it is evident that the trimer in our BG505 SOSIP-sCD4-
17b-8ANC195G52K5 structure is not in a closed conformation
(Figure 6). As expected, given that the trimer is not closed, the
placement of 8ANC195G52K5 in the EM structure is shifted
somewhat from its placement in the 8ANC195G52K5-BG505
SOSIP (closed trimer) crystal structure (Figure S6). To determine
whether the trimer in the EM structure is fully open, we
investigated the arrangement of 17b Fabs, noting that they
are positioned differently in the BG505 SOSIP-sCD4-17b-1386 Cell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc.8ANC195G52K5 structure than in open trimer structures (Figures
6A and 6B) (Harris et al., 2011; Liu et al., 2008; Sanders et al.,
2013; Tran et al., 2012), suggesting that the trimer in the
BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex is less open
than in other sCD4-bound or 17b-bound structures. To more
precisely describe the conformational state of the Env trimer in
the BG505 SOSIP-sCD4-17b-8ANC195G52K5 complex, we
measured distances between a CD4bs residue in each gp120
protomer of the trimer and compared them to the corresponding
distances in structures of trimers in different conformational
states (Figures 1C and 6C and Table S5). This comparison
showed that the trimer in the BG505 SOSIP-sCD4-17b-
8ANC195G52K5 structure adopts a previously unseen partially
open state that is midway between a partially open state
observed for Env bound to either b12 (a CD4bs Ab) or A12
VHH (a CD4bs llama Ab fragment) and the open state observed
for the sCD4/17b-bound open trimer (Merk and Subramaniam,
2013). Thus, addition of 8ANC195G52K5 Fab to the BG505
SOSIP-sCD4-17b complex resulted in partial closure of the
trimer, suggesting that stable 8ANC195G52K5 binding is incom-
patible with a fully open Env trimer conformation and would
therefore block conformational changes leading to fusion be-
tween the viral and host membranes.
DISCUSSION
Here, we present an atomic resolution structure of
8ANC195G52K5 bound to BG505 SOSIP, a native-like soluble
HIV-1 Env trimer in the closed, prefusion conformation. The
interface of 8ANC195G52K5 with Env trimer (5,645 A˚
2 total buried
surface area) is much larger than typical Ab-antigen complexes
(Jones and Thornton, 1996), and 8ANC195 uses a large propor-
tion of its accessible surface to engage its antigen, primarily
using CDRs to contact protein portions and framework regions
to contact glycan portions of the epitope. The structure solidifies
previous evidence that the 8ANC195 epitope spans gp120 and
gp41 (Scharf et al., 2014) and reveals details of extensive interac-
tions withN-linked glycans on both gp120 and gp41. Rather than
penetrating the glycan shield of HIV-1 Envwith only a single loop,
a strategy employed by Abs such as PG9 and PGT128 (McLellan
et al., 2011; Pejchal et al., 2011), 8ANC195 inserts its entire
variable region into a gap in the Env trimer glycan shield at the
interface of gp120 and gp41. 8ANC195 makes productive inter-
actions with gp120 glycans at Asn234gp120 and Asn276gp120,
since neutralization potency decreases when these glycosyla-
tion sites are knocked out (West et al., 2013). However, the
mature Ab appears to accommodate, rather than productively
contact, gp41 glycans, e.g., the Asn637gp41 glycan, since the
neutralization potency of 8ANC195 is not affected when this
glycan is removed despite the large contact area between the
Asn637gp41 glycan and 8ANC195G52K5.
In addition to recognizing both gp120 monomer and closed
Env trimer, we also provide SPR and EM evidence that
8ANC195 can bind to Env trimers complexed with sCD4 and
the CD4-induced Ab 17b. CD4 binding normally induces an
open state of both virion-bound and soluble HIV-1 Env trimers
involving rotation of gp120 subunits away from the center axis
of the trimer (Harris et al., 2011; Liu et al., 2008; Sanders et al.,
2013; Tran et al., 2012). However, despite recognizing an epitope
that spans the gp120-gp41 interface, a region thought to un-
dergo conformational changes upon CD4 binding to allow rota-
tion of the gp120 subunits, 8ANC195 binds CD4-bound Env
trimers with little to no decrease in affinity compared with closed,
non-CD4-bound trimers. 17b, which binds at the apex of Env
trimer, prevents reclosing of Env trimer that has opened upon
CD4 binding because three 17b Fabs cannot be accommodated
on a closed Env trimer (Figure 6A). Thus, our EM structure of a
partially open BG505 SOSIP-sCD4-17b-8ANC195 complex
suggests that 8ANC195 binding to fully open CD4-bound Env
trimers results in a conformational change toward the closed
state but that complete closure of the trimer is prevented by
steric clashing of 17b Fabs. Alternatively, when Env trimer is
bound to CD4, 8ANC195 could stabilize a partially open
conformation in equilibrium with fully open CD4-bound Env.
Taken together with our crystal structure showing a closed
8ANC195G52K5-bound trimer despite pre-incubation of trimer
with sCD4, the observation that the trimer in the BG505
SOSIP-sCD4-17b-8ANC195G52K5 complex is partially, rather
than fully, open implies that 8ANC195 prefers binding to the
closed trimer. This suggests that its mechanism of neutralization
likely involves preventing the complete conformational change
necessary for the trimer to bind co-receptor and/or expose the
fusion peptide and fuse with the target cell membrane.
Although our results suggest that 8ANC195 preferentially rec-
ognizes closed Env trimers, its ability to also recognize other
Env conformations suggests that 8ANC195 can neutralize virions
regardless of Env conformational state, including virions withCconstitutively open spikes such as those found on CD4-indepen-
dent strains (White et al., 2010, 2011). It also suggests that,
in addition to neutralizing free virions, 8ANC195 could neutralize
virions already engaged by CD4 at a target cell membrane. This
is a useful property of an HIV-1 bNAb since Abs with these prop-
erties could inhibit cell-to-cell spread of HIV-1, which is most
effectively prevented by Abs that bind triggered Env conforma-
tions (Abela et al., 2012). Finally, recent evidence from single-
molecule FRET studies (Munro et al., 2014) and molecular ruler
measurements of virion-associated Env trimers (Galimidi et al.,
2015) suggests that Env on free virions can exhibit transitions
from the closed state to more open conformations; thus, recog-
nition of Env states other than the closed state should be useful
for neutralization of cell-bound as well as free virions.
The finding that the trimer in our BG505 SOSIP-sCD4-17b-
8ANC195G52K5 complex structure was partially, rather than fully,
open, as observed in previous CD4-, 17b-, and CD4/17b-bound
trimer structures (Harris et al., 2011; Liu et al., 2008; Sanders
et al., 2013; Tran et al., 2012), suggests that the trimer re-closed
somewhat upon 8ANC195 binding. This result implies more
structural plasticity of HIV-1 Env than previously assumed and
prompts reevaluation of current models for target cell fusion by
Env after CD4 engagement to address, for example, whether
the partially closed CD4-bound structure revealed in this
work can engage co-receptors. We hypothesize that, when
8ANC195 engages a CD4-bound (open) trimer, it partially reclo-
ses the trimer or captures and stabilizes a pre-existing confor-
mation because the complex with a partially open trimer is
more favorable for Ab binding. This reclosing of the trimer may
result in dissociation of CD4, either due to steric constraints on
partially open trimers or the relatively low affinity of sCD4 for
trimer (600 nM) (Julien et al., 2013b). In stabilized soluble Env
trimers, 8ANC195 binding may result in complete re-closure of
the trimer, as observed in our BG505 SOSIP-8ANC195G52K5
crystal structure. This model suggests that CD4 engagement
of HIV-1 spike trimers does not lead to an immediate irreversible
conformational change but, rather, that the conformational
change is reversible as long as no major rearrangement of
gp41 has occurred. Alternatively, the highly stabilized design of
SOSIP trimers may be responsible for the apparent reversibility
of CD4-induced conformational changes. However, single-
molecule FRET experiments on HIV-1 virions showed that mem-
brane-bound Env trimers sample three distinct conformational
states in the absence of ligands and that ligands such as Abs
and CD4 only changed the sizes of the populations occupying
each state (Munro et al., 2014). The FRET study reported a
sequence of conformational changes in unbound trimer involving
transitions from closed to fully open, open to partially open, and
then partially open to closed, supporting our hypothesis that
membrane-bound Env trimers can re-close from a fully open
state spontaneously, a process that may be assisted by an Ab
that prefers to engage the closed state.
Combinations of bNAbs are being considered for treatment
and prevention of HIV-1 infection by passive delivery methods
because mixtures of active molecules (bNAbs or small molecule
drugs) are required to prevent the appearance of escape
mutants in a rapidly mutating virus such as HIV-1 (Horwitz
et al., 2013; Klein et al., 2012). Two or more bNAbs targetingell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc. 1387
different epitopes are favored because the virus is presumed
unable to mutate several potentially conserved sites simulta-
neously. In addition to targeting an epitope distinct from other
known bNAbs, 8ANC195 can accommodate different conforma-
tional states (including a CD4-bound state), making it an attrac-
tive candidate for use in combination therapies with bNAbs that
(1) cannot tolerate such changes, (2) are unable to engage a
CD4-bound open trimer, and/or (3) allow HIV-1 to spread
through cell-to-cell transmission, as is the case for potent
CD4-binding site Abs in the VRC01 family (Abela et al., 2012).
8ANC195 may also be a target for vaccine development since
it targets conserved regions on Env such as gp41 and the
Asn276gp120 glycan.
EXPERIMENTAL PROCEDURES
Detailed methods are provided in the Supplemental Experimental Procedures.
Protein Production and Purification
8ANC195, 8ANC195G52K5, 17b, PGT145, mG053, 2G12, CD4-Fc (domains 1
and 2 of human CD4 fused to human IgG1 Fc), human IgG1 Fc, and partially
gl-reverted IgGs and/or Fabs were produced by transient transfection and
purified using affinity chromatography and SEC, as described in previous
studies (Diskin et al., 2011; Scharf et al., 2014). sCD4 (domains 1 and 2; resi-
dues 1–186 of mature CD4) was produced in baculovirus-infected Hi5 insect
cells and was purified using affinity chromatography and SEC, as described
previously (Diskin et al., 2010; Scharf et al., 2014). Untagged BG505
SOSIP.664 was constructed, expressed, and purified as described (Sanders
et al., 2013). In brief, HEK293-6E cells treated with 5 mM kifunensine (Sigma)
were co-transfected with plasmids encoding BG505 SOSIP.664 and soluble
furin, and trimers were purified from cell supernatants using a 2G12 immunoaf-
finity chromatography and SEC.
Crystallization
Samples for crystallography were produced by incubating BG505 SOSIP with
a 3-fold molar excess of sCD4 and were purified by SEC. The resulting com-
plex was incubated with a 3-fold molar excess of 8ANC195G52K5 Fab and
purified by SEC. Crystals of 8ANC195G52K5 Fab-BG505 SOSIP (space group
P21; a = 117.74 A˚, b = 195.22 A˚, c = 119.09 A˚; b = 101.6
) were obtained in
100mMTris (pH 8.0), 15%PEG 3,350, and 2%1,4-dioxane at 20C and frozen
in liquid N2 after cryoprotection.
Crystallographic Data Collection, Structure Determination, and
Refinement
X-ray diffraction data were collected at the Argonne National Laboratory
Advanced Photon Source (APS) beamline 23-ID-D using a Pilatus3 6M detec-
tor and were processed using XDS (Kabsch, 2010). The structure was solved
by molecular replacement using a trimeric model of BG505 SOSIP (PDB:
4TVP) and three copies of 8ANC195 Fab (PDB: 4P9M). The model was refined
to 3.58 A˚ using Phenix (Adams et al., 2010) and manual model building in Coot
(Emsley and Cowtan, 2004). In the final model (Rwork = 24.1%; Rfree = 28.6%),
96%, 4%, and 0%of the residues were in the favored, allowed, and disallowed
regions, respectively, of the Ramachandran plot.
SPR
Experiments were performed using a Biacore T200 (Biacore). Protein A
coupled on a CM5 chip (Biacore) was used to immobilize capture proteins
(PGT145 IgG, PGT121 IgG, CD4-Fc, 17b IgG, 21C IgG, or mG053 IgG control),
followed by injection of human Fc to block remaining protein A binding sites.
BG505 SOSIP was subsequently injected and washed with running buffer
(HBS-EP+, GE Healthcare). 8ANC195, 8ANC195G52K5, and mutant/chimeric
Fabs were injected over flow cells at increasing concentrations (1.95 to
1,000 nM) at flow rates of 50 ml/min for 180 s and were allowed to dissociate
for 600 s. Flow cells were regenerated with one pulse each of 10 mM glycine1388 Cell 162, 1379–1390, September 10, 2015 ª2015 Elsevier Inc.(pH 2.5) and 1 M guanidine HCl at a flow rate of 90 ml/min. On/off rates
(ka/kd) and binding constants (KDs) were calculated by kinetic analyses after
subtraction of backgrounds using a 1:1 binding model with or without a bulk
reflective index (RI) correction as appropriate (Biacore T200 Evaluation
software).
Cryoelectron Tomography
Purified BG505 SOSIP-sCD4-17b-8ANC195G52K5 complexes were diluted
to 60 mg/ml in TBS immediately before plunge freezing to avoid complex disso-
ciation at low concentration. Quantifoil R2/2 NH2 copper finder grids were vitri-
fied in liquid ethane using a Mark IV Vitrobot (FEI Company) and Tilt series
(±60, 1 angular increments) were collected on a FEI Tecnai G2 Polara trans-
mission electron microscope equipped with 300 keV FEG, a Gatan energy
filter, and aGatan K2 Summit direct detector using theUCSF tomography soft-
ware package (Zheng et al., 2007) under low-dose conditions (120 e–/A˚2 total
for the tilt series at 8 mm underfocus) at a nominal magnification of 41,0003
so that each pixel represented 2.6 A˚. Tomographic reconstructions and CTF
corrections were calculated using IMOD (Kremer et al., 1996). Subtomogram
averaging of 1,745 subvolumes was performed using PEET (Nicastro et al.,
2006) without an external reference or applying C3 symmetry, resulting in a
23 A˚ structure estimated by a 0.143 gold-standard Fourier shell correlation
(FSC) calculated using IMOD (Kremer et al., 1996).
Negative-Stain Single-Particle EM
Purified BG505 SOSIP-sCD4-17b-8ANC195G52K5 complexes were diluted to
10 mg/ml in TBS immediately before adding 3 ml to a glow discharged ultrathin
C film on holey carbon support film, 400mesh, Cu grids (Ted Pella) followed by
cross-linking using glutaraldehyde vapor and staining with uranyl acetate.
Data were collected using a FEI Tecnai T12 transmission electron microscope
operating at 120 keV equipped with a Gatan Ultrascan 2k 3 2k CCD using a
0.5 s exposure time at a nominal magnification of 42,0003 at 1 mm defocus,
resulting in 2.5 A˚ per pixel. A total of 23,951 particles were picked using
EMAN2.1 (Tang et al., 2007) and RELION (Scheres, 2012), and the CTF correc-
tion was done using EMAN2.1. Initial reference-free 2D class averaging was
performed using RELION, and the particles were further sorted using 3D clas-
sification in RELION. Refinement was conducted using 80 A˚ low-pass-filtered
structures calculated from models of 8ANC195-sCD4-17b docked onto
gp120 cores of partially open (PDB: 3DNL) trimer and 7,174 particles with
C3 symmetry applied. The resolution of the final reconstruction was 17 A˚
calculated with RELION (Scheres, 2012) using a gold-standard FSC and a
0.143 cutoff, as recommended for resolution estimations for single-particle
EM reconstructions (Scheres and Chen, 2012). Coordinates from crystal struc-
tureswere fit into the sub-tomogram averaged or negative-stain single-particle
EM structures using UCSF Chimera (Pettersen et al., 2004).ACCESSION NUMBERS
Crystallographic atomic coordinates and structure factors were deposited in
the Protein Data Bank under accession code PDB: 5CJX. EM reconstructions
were deposited in the Electron Microscopy Data Bank under accession codes
EMD: 3086 and EMD: 3096.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and five tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2015.08.035.
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